Eli Lilly (Japan)

522 papers and 8.1k indexed citations i.

About

In recent decades, authors affiliated with Eli Lilly (Japan) have published 522 papers, which have received a total of 8.1k indexed citations. Scholars at this organization have produced 116 papers in Oncology, 108 papers in Pulmonary and Respiratory Medicine and 104 papers in Endocrinology, Diabetes and Metabolism on the topics of Diabetes Treatment and Management (77 papers), Diabetes Management and Research (58 papers) and Colorectal Cancer Treatments and Studies (45 papers). Their work is cited by papers focused on Oncology (2.0k citations), Endocrinology, Diabetes and Metabolism (1.7k citations) and Molecular Biology (1.5k citations). Authors at Eli Lilly (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Blood and PLoS ONE. Some of Eli Lilly (Japan)'s most productive authors include Takeshi Imaoka, Tomonori Oura, Masakazu Takeuchi, Kaname Ueda, William Montgomery, Yoji Morisaki, Taeko Ishii, Levent Alev, Zhihong Cai and Mika Tsujimoto.

In The Last Decade

Fields of papers published by authors at Eli Lilly (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Eli Lilly (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Eli Lilly (Japan) at the time of their publication.

Countries citing scholars working at Eli Lilly (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025